Project Grant R16EB039694
- The National Institute of Biomedical Imaging and Bioengineering awarded Iowa State University of Science and Technology $215,723 on August 14, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a next-generation, handheld, battery-powered, wireless dual-mode ultrasound-photoacoustic imaging system integrating high-power nanosecond pulsed light-emitting diodes. The project addresses a gap in current imaging...
- The National Institute of Biomedical Imaging and Bioengineering awarded $182,558 to Iowa State University of Science and Technology on May 6, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a bioinspired drug discovery strategy for personalized combination immunoregulatory therapeutics. The research leverages the foreign body response within subcutaneous biomaterial scaffold implants to identify...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of North Dakota $192,065 on August 15, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a dual-immersion bidirectional light sheet microscopy platform for volumetric imaging across intestinal tissue layers. The project addresses limitations in current imaging tools for capturing dynamic cellular processes in intact...
- The National Institute of General Medical Sciences awarded Idaho State University $239,113 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to integrate an Emulate organ-on-a-chip system into the university's Pharmaceutical Sciences Core. The organ-on-a-chip platform uses microengineered chips lined with living human cells to replicate human organ function, providing a physiologically relevant alternative to conventional in vitro and animal...
- The National Institute of Dental and Craniofacial Research awarded Idaho State University $249,779 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to acquire a FluoView FV4000 confocal microscope for the university's Advanced Imaging Facility in Pocatello, Idaho. The FV4000 confocal microscope will replace an obsolete FV1000 unit and support high-resolution imaging and three-dimensional reconstruction of spatial organization in fixed and live cells...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of California, Los Angeles $244,897 on August 18, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and validate AI approaches that enhance transparency and clinical generalizability of foundation models in radiology imaging diagnostics. The project focuses on lung disease detection on chest X-rays using two specific...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Washington University $119,818 on July 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop AI-powered gradient echo plural contrast imaging (AI-GEPCI) technology for early detection and monitoring of progressive multiple sclerosis. The award funds development of an integrated neuroimaging platform that combines deep learning with...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $1,364,828 on April 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to conduct research on safe, effective, and trustworthy artificial intelligence deployment across U.S. healthcare delivery organizations. The project uses mixed methods to identify barriers to and mitigation strategies for AI capability...
- The National Institute of Biomedical Imaging and Bioengineering awarded Rensselaer Polytechnic Institute $366,006 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a simulation-based inference framework that transforms functional near-infrared spectroscopy (fNIRS) data analysis through artificial intelligence. The project delivers a biophysically detailed simulator integrating realistic models...
- The National Institute of Biomedical Imaging and Bioengineering awarded $414,079 to the University of North Carolina at Chapel Hill on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286, R21 mechanism) to develop factual medical large vision-language models for radiology that reduce hallucinations in AI-generated medical image analyses. The project addresses hallucinations in medical large vision-language models...
The National Institute of Biomedical Imaging and Bioengineering awarded the University of Idaho $139,208 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and validate an AI-enhanced multimodal conversational virtual patient system for medical education. The project will create an interactive training platform that integrates medical imaging with clinical dialogue using large language models and vision-language models to improve how medical students learn complex diagnoses. Specific deliverables include an AI framework for automated generation of clinically plausible patient profiles that fuse medical images with clinical narratives; an interactive conversational virtual patient system capable of real-time, multimodal dialogue with feedback on diagnostic accuracy via image analysis and communication skills via speech and text analysis; and validation of the system's educational efficacy, usability, and pedagogical impact through a pilot course in dermoscopy diagnosis at a medical school, with data collection from student and faculty surveys and focus groups. The system will support dynamic generation of diverse patient scenarios including rare pathologies and real-time feedback on both diagnostic and communication competencies. Work is performed in Moscow, Idaho, with performance extending through June 30, 2030. The award funds hypothesis-driven research related to discovery, design, development, validation, and application of biomedical imaging and bioengineering technologies as specified by the NIBIB program authority.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $139.2k | 8/25/26 |